Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

It’s not yet known how many people have gotten sick in the Texas measles outbreak, but there are at least 215 confirmed cases since late January.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...

The main symptom of chickenpox is an itchy, spotty rash that can be anywhere on the body. Chickenpox happens in three stages, ...

To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...

A common vaginal infection that affects nearly 1 in 3 women worldwide should be reclassified as a sexually transmitte ...

Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs) or venereal diseases, are infections spread primarily through ...